Loading...
LBT Innovations Limited
LBT.AX•ASX
Healthcare
Medical - Devices
A$0.02
A$0.00(0.00%)
LBT Innovations Limited (LBT.AX) Financial Performance & Income Statement Overview
Explore the financials of LBT Innovations Limited (LBT.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
-41.09%
↓ 41.09%
Operating Income Growth
33.62%
↑ 33.62%
Net Income Growth
83.40%
↑ 83.40%
Operating Cash Flow Growth
-162.73%
↓ 162.73%
Operating Margin
-365.37%
↓ 365.37%
Gross Margin
-232.25%
↓ 232.25%
Net Profit Margin
-297.77%
↓ 297.77%
ROE
-150.35%
↓ 150.35%
ROIC
-71.65%
↓ 71.65%
LBT Innovations Limited (LBT.AX) Income Statement & Financial Overview
Explore comprehensive income reports for LBT Innovations Limited LBT.AX, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $545000.00 | $711000.00 | $1.27M | $859000.00 |
| Cost of Revenue | $2.08M | $2.09M | $3.44M | $4.32M |
| Gross Profit | -$1.54M | -$1.38M | -$2.16M | -$3.46M |
| Gross Profit Ratio | -$2.82 | -$1.94 | -$1.70 | -$4.03 |
| R&D Expenses | $518000.00 | $147000.00 | $185000.00 | -$110000.00 |
| SG&A Expenses | $635000.00 | $372000.00 | $585000.00 | $633000.00 |
| Operating Expenses | $1.15M | $519000.00 | $770000.00 | $523000.00 |
| Total Costs & Expenses | $3.24M | $2.61M | $4.21M | $4.84M |
| Interest Income | $39000.00 | $15000.00 | $7000.00 | $10000.00 |
| Interest Expense | $51000.00 | $337000.00 | $408000.00 | $62000.00 |
| Depreciation & Amortization | $115000.00 | $123000.00 | $1.65M | $1.65M |
| EBITDA | -$2.36M | -$1.69M | -$14.64M | -$2.48M |
| EBITDA Ratio | -$4.33 | -$2.50 | -$1.01 | -$2.72 |
| Operating Income | -$2.69M | -$1.90M | -$2.93M | -$3.98M |
| Operating Income Ratio | -$4.94 | -$2.67 | -$2.30 | -$4.64 |
| Other Income/Expenses (Net) | $164000.00 | -$250000.00 | -$13.76M | -$204000.00 |
| Income Before Tax | -$2.53M | -$2.15M | -$16.69M | -$4.19M |
| Income Before Tax Ratio | -$4.64 | -$3.02 | -$13.11 | -$4.88 |
| Income Tax Expense | -$619000.00 | -$316000.00 | $2.85M | -$1.21M |
| Net Income | -$1.91M | -$1.83M | -$19.54M | -$2.98M |
| Net Income Ratio | -$3.50 | -$2.58 | -$15.35 | -$3.47 |
| EPS | -$0.001 | -$0.003 | -$0.04 | -$0.006 |
| Diluted EPS | -$0.001 | -$0.003 | -$0.04 | -$0.006 |
| Weighted Avg Shares Outstanding | $1.55B | $572.50M | $472.55M | $462.89M |
| Weighted Avg Shares Outstanding (Diluted) | $1.55B | $572.50M | $472.55M | $462.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan